Insulin Pricing MDL 3080 Lawsuit 2026: Who Can Sue Lilly, Novo Nordisk, Sanofi and the PBMs
A practical breakdown of MDL 3080, the insulin pricing and rebate litigation consolidated in federal court in New Jersey against Eli Lilly, Novo Nordisk, Sanofi, and PBMs CVS Caremark, Express Scripts, and OptumRx. Covers who qualifies to file, how the rebate and spread pricing scheme actually works, the FTC's separate track, settlement timing, and how to evaluate a claim before you sign anything.